Advertisement

Sports Medicine

, Volume 44, Issue 8, pp 1025–1036 | Cite as

Considerations for the Use of Platelet-Rich Plasma in Orthopedics

  • Taralyn M. McCarrel
  • Nathan A. Mall
  • Andrew S. Lee
  • Brian J. Cole
  • Davietta C. Butty
  • Lisa A. FortierEmail author
Current Opinion

Abstract

The use of platelet-rich plasma (PRP) is expanding to numerous medical fields, including orthopedic surgery and sports medicine. The popularity of this new treatment option has prompted a rapid increase in research endeavors; however, the differences in application technique and the composition of PRP have made it difficult to compare results or make any firm conclusions regarding efficacy. The purpose of this article is twofold. First, to recommend details that should be provided in basic science and clinical PRP studies to allow meaningful comparisons between studies which may lead to a better understanding of efficacy. Second, to provide an understanding of the different PRP preparations and their clinical relevance. There are biochemical rationales for the use of PRP because it addresses several aspects of the healing process, including cell proliferation and tissue matrix regeneration, inflammation, nociception, infection, and hemostasis, all of which will be addressed. Given the current understanding of the importance the composition of PRP plays in tissue regeneration, it is likely that our future understanding of PRP will dictate ‘customizing’ the PRP preparation to the specific pathology of interest. The potential complications following PRP use are minor, and thus it appears to be a safe treatment option with a variety of potentially beneficial effects to injured musculoskeletal tissues.

Keywords

Rotator Cuff Patellar Tendon Platelet Concentration Arthroscopic Rotator Cuff Repair Anterior Cruciate Ligament Repair 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

Harry M. Zweig Memorial Fund for Equine Research (Lisa A. Fortier), LiveActive Foundation, Rush-Presbyterian St. Luke’s Medical Center (Brian J. Cole) for funding of orthopedic research. Brian J. Cole and Lisa A. Fortier are both consultants to Arthrex, Inc. (Naples, FL, USA).

References

  1. 1.
    Boswell SG, Cole BJ, Sundman EA, et al. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012;28:429–39.PubMedCrossRefGoogle Scholar
  2. 2.
    Sheth U, Simunovic N, Klein G, et al. Efficacy of autologous platelet-rich plasma use for orthopaedic indications: a meta-analysis. J Bone Joint Surg Am. 2012;94:298–307.PubMedCrossRefGoogle Scholar
  3. 3.
    Amable PR, Carias RB, Teixeira MV, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4:67.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Jin R, Zhang L, Zhang YG. Does platelet-rich plasma enhance the survival of grafted fat? An update review. Int J Clin Exp Med. 2013;6:252–8.PubMedCentralPubMedGoogle Scholar
  5. 5.
    Arnoczky SP, Delos D, Rodeo SA. What is platelet-rich plasma? Oper Tech Sports Med. 2011;19:142–8.CrossRefGoogle Scholar
  6. 6.
    Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94:308–16.PubMedCrossRefGoogle Scholar
  7. 7.
    Vasconcelos E, Figueiredo AC, Seghatchian J. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and apheresis. Transfus Apher Sci. 2003;29:13–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Singh RP, Marwaha N, Malhotra P, et al. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods. Asian J Transfus Sci. 2009;3(2):86–94.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    de Vries RA, de Bruin M, Marx JJM, et al. Viability of platelets collected by apheresis versus the platelet-rich plasma technique: a direct comparison. Transfus Sci. 1993;14:391–8.PubMedCrossRefGoogle Scholar
  10. 10.
    van der Meer PF. Platelet concentrates, from whole blood or collected by apheresis? Transfus Apher Sci. 2013;48:129–31.PubMedCrossRefGoogle Scholar
  11. 11.
    Anitua E, Zalduendo MM, Alkhraisat MH, et al. Release kinetics of platelet-derived and plasma-derived growth factors from autologous plasma rich in growth factors. Ann Anat. 2013;195(5):461–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Browning SR, Weiser AM, Woolf N, et al. Platelet-rich plasma increases matrix metalloproteinases in cultures of human synovial fibroblasts. J Bone Joint Surg Am. 2012;94:e1721–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39:2135–40.PubMedCrossRefGoogle Scholar
  14. 14.
    Muylle L, Joos M, Wouters E, et al. Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions. Transfusion. 1993;33:195–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Muylle L, Peetermans ME. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang. 1994;66:14–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Muylle L, Wouters E, Peetermans ME. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion. 1996;36:886–90.PubMedCrossRefGoogle Scholar
  17. 17.
    Stack G, Snyder EL. Cytokine generation in stored platelet concentrates. Transfusion. 1994;34:20–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Aye MT, Palmer DS, Giulivi A, et al. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion. 1995;35:117–24.PubMedCrossRefGoogle Scholar
  19. 19.
    Palmer DS, Aye MT, Dumont L, et al. Prevention of cytokine accumulation in platelets obtained with the COBE spectra apheresis system. Vox Sang. 1998;75:115–23.PubMedCrossRefGoogle Scholar
  20. 20.
    Halpern B, Chaudhury S, Rodeo SA, et al. Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis. Clin J Sport Med. 2013;23(3):238–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Pillitteri D, Bassus S, Boller K, et al. Thrombin-induced interleukin 1beta synthesis in platelet suspensions: impact of contaminating leukocytes. Platelets. 2007;18:119–27.PubMedCrossRefGoogle Scholar
  22. 22.
    Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27:158–67.PubMedCrossRefGoogle Scholar
  23. 23.
    Mishra A, Harmon K, Woodall J, et al. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012;13:1185–95.PubMedCrossRefGoogle Scholar
  24. 24.
    Anitua E, Sanchez M, Zalduendo MM, et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif. 2009;42:162–70.PubMedCrossRefGoogle Scholar
  25. 25.
    Weibrich G, Hansen T, Kleis W, et al. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone. 2004;34:665–71.PubMedCrossRefGoogle Scholar
  26. 26.
    Sadoghi P, Lohberger B, Aigner B, et al. Effect of platelet-rich plasma on the biologic activity of the human rotator-cuff fibroblasts: a controlled in vitro study. J Orthop Res. 2013;31:1249–53.PubMedCrossRefGoogle Scholar
  27. 27.
    Fortier LA, Hackett CH, Cole BJ. The effects of platelet-rich plasma on cartilage: basic science and clinical application. Oper Tech Sports Med. 2011;19:154–9.CrossRefGoogle Scholar
  28. 28.
    McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am. 2012;94:e143(1–8).Google Scholar
  29. 29.
    Dallaudiere B, Lempicki M, Pesquer L, et al. Efficacy of intra-tendinous injection of platelet-rich plasma in treating tendinosis: comprehensive assessment of a rat model. Eur Radiol. 2013;23:2830–7.PubMedCrossRefGoogle Scholar
  30. 30.
    McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009;27:1033–42.PubMedCrossRefGoogle Scholar
  31. 31.
    Aspenberg P, Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand. 2004;75:93–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Bosch G, van Schie HT, de Groot MW, et al. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: a placebo-controlled experimental study. J Orthop Res. 2010;28:211–7.PubMedGoogle Scholar
  33. 33.
    Fleming BC, Spindler KP, Palmer MP, et al. Collagen-platelet composites improve the biomechanical properties of healing anterior cruciate ligament grafts in a porcine model. Am J Sports Med. 2009;37:1554–63.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Lyras D, Kazakos K, Verettas D, et al. Immunohistochemical study of angiogenesis after local administration of platelet-rich plasma in a patellar tendon defect. Int Orthop. 2010;34:143–8.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Schnabel LV, Mohammed HO, Miller BJ, et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res. 2007;25:230–40.PubMedCrossRefGoogle Scholar
  36. 36.
    Schnabel LV, Mohammed HO, Jacobson MS, et al. Effects of platelet rich plasma and acellular bone marrow on gene expression patterns and DNA content of equine suspensory ligament explant cultures. Equine Vet J. 2008;40:260–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Van Miert AS. Present concepts on the inflammatory modulators with special reference to cytokines. Vet Res Commun. 2002;26:111–26.PubMedCrossRefGoogle Scholar
  38. 38.
    Klein MB, Yalamanchi N, Pham H, et al. Flexor tendon healing in vitro: effects of TGF-beta on tendon cell collagen production. J Hand Surg [Am]. 2002;27:615–20.CrossRefGoogle Scholar
  39. 39.
    Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg. 1993;165:728–37.PubMedCrossRefGoogle Scholar
  40. 40.
    Tsuzaki M, Guyton G, Garrett W, et al. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res. 2003;21:256–64.PubMedCrossRefGoogle Scholar
  41. 41.
    Chahal J, Van Thiel GS, Mall N, et al. The role of platelet-rich plasma in arthroscopic rotator cuff repair: a systematic review with quantitative synthesis. Arthroscopy. 2012;28(11):1718–27.PubMedCrossRefGoogle Scholar
  42. 42.
    Zhang Q, Ge H, Zhou J, et al. Are platelet-rich products necessary during the arthroscopic repair of full-thickness rotator cuff tears: a meta-analysis. PLoS ONE. 2013;8(7):e69731. doi: 10.1371/journal.pone.0069731.PubMedCentralPubMedCrossRefGoogle Scholar
  43. 43.
    Mautner K, Colberg RE, Malanga G, et al. Outcomes after ultrasound-guided platelet-rich plasma injections for chronic tendinopathy: a multicenter, retrospective review. PM R. 2013;5:169–75.PubMedCrossRefGoogle Scholar
  44. 44.
    de Almeida AM, Demange MK, Sobrado MF, et al. Patellar tendon healing with platelet-rich plasma: a prospective randomized controlled trial. Am J Sports Med. 2012;40(6):1282–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Noth U, Rackwitz L, Heymer A, et al. Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels. J Biomed Mater Res A. 2007;83:626–35.PubMedCrossRefGoogle Scholar
  46. 46.
    Frazer A, Bunning RA, Thavarajah M, et al. Studies on type II collagen and aggrecan production in human articular chondrocytes in vitro and effects of transforming growth factor-beta and interleukin-1beta. Osteoarthritis Cartilage. 1994;2:235–45.PubMedCrossRefGoogle Scholar
  47. 47.
    Schmidt MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage. 2006;14:403–12.PubMedCrossRefGoogle Scholar
  48. 48.
    O’Keefe RJ, Crabb ID, Puzas JE, et al. Effects of transforming growth factor-beta 1 and fibroblast growth factor on DNA synthesis in growth plate chondrocytes are enhanced by insulin-like growth factor-I. J Orthop Res. 1994;12:299–310.PubMedCrossRefGoogle Scholar
  49. 49.
    Spreafico A, Chellini F, Frediani B, et al. Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem. 2009;108:1153–65.PubMedCrossRefGoogle Scholar
  50. 50.
    Lippross S, Moeller B, Haas H, et al. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint. Arthritis Rheum. 2011;63:3344–53.PubMedCrossRefGoogle Scholar
  51. 51.
    Yin Z, Yang X, Jiang Y, et al. Platelet-rich plasma combined with agarose as a bioactive scaffold to enhance cartilage repair: an in vitro study. J Biomater Appl. 2014;28:1039–50. doi: 10.1177/0885328213492573.PubMedCrossRefGoogle Scholar
  52. 52.
    Bendinelli P, Matteucci E, Dogliotti G, et al. Molecular basis of anti-inflammatory action of platelet rich plasma on human chondrocytes: mechanisms of NF-kB inhibition via HGF. J Cell Physiol. 2010;225:757–66.PubMedCrossRefGoogle Scholar
  53. 53.
    van Buul GM, Koevoet WL, Kops N, et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports Med. 2011;39:2362–70.PubMedCrossRefGoogle Scholar
  54. 54.
    Andia I, Sanchez M, Maffulli N. Joint pathology and platelet-rich plasma therapies. Expert Opin Biol Ther. 2012;12:7–22.PubMedCrossRefGoogle Scholar
  55. 55.
    Taylor DW, Petrera M, Hendry M, et al. A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med. 2011;21:344–52.PubMedCrossRefGoogle Scholar
  56. 56.
    Gumina S, Campagna V, Ferrazza G, et al. Use of platelet-leukocyte membrane in arthroscopic repair of large rotator cuff tears: a prospective randomized study. J Bone Joint Surg Am. 2012;94:1345–52.PubMedCrossRefGoogle Scholar
  57. 57.
    Rodeo SA, Delos D, Williams RJ, et al. The effect of platelet-rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. Am J Sports Med. 2012;40:1234–41.PubMedCrossRefGoogle Scholar
  58. 58.
    Gosens T, Peerbooms JC, van Laar W, et al. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011;39:1200–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Thanasas C, Papadimitriou G, Charalambidis C, et al. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. Am J Sports Med. 2011;39:2130–4.PubMedCrossRefGoogle Scholar
  60. 60.
    Creaney L, Wallace A, Curtis M, et al. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med. 2011;45:966–71.PubMedCrossRefGoogle Scholar
  61. 61.
    Mishra AK, Skrepnik NV, Edwards SG, et al. Platelet-rich plasma significantly improves clinical outcomes in patients with chronic tennis elbow: a double-blind, prospective, multicenter, controlled trial of 230 patients. Am J Sports Med. 2014;42(2):143–8. doi: 10.1177/0363546513494359.Google Scholar
  62. 62.
    Krogh TP, Fredberg U, Stengaard-Pedersen K, et al. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. Am J Sports Med. 2013;41:625–35.PubMedCrossRefGoogle Scholar
  63. 63.
    Filardo G, Kon E, Di Matteo B, et al. Platelet-rich plasma for the treatment of patellar tendinopathy: clinical and imaging findings at medium-term follow-up. Int Orthop. 2013;37:1583–9.PubMedCrossRefGoogle Scholar
  64. 64.
    Vetrano M, Castorina A, Vulpiani MC, et al. Platelet-rich plasma versus focused shock waves in the treatment of jumper’s knee in athletes. Am J Sports Med. 2013;41:795–803.PubMedCrossRefGoogle Scholar
  65. 65.
    Gosens T, Den Oudsten BL, Fievez E, et al. Pain and activity levels before and after platelet-rich plasma injection treatment of patellar tendinopathy: a prospective cohort study and the influence of previous treatments. Int Orthop. 2012;36:1941–6.PubMedCentralPubMedCrossRefGoogle Scholar
  66. 66.
    Filardo G, Kon E, Pereira Ruiz MT, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012;20(10):2082–91.PubMedCrossRefGoogle Scholar
  67. 67.
    Cerza F, Carni S, Carcangiu A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012;40:2822–7.PubMedCrossRefGoogle Scholar
  68. 68.
    Gobbi A, Karnatzikos G, Mahajan V, et al. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health. 2012;4:162–72.PubMedCentralPubMedCrossRefGoogle Scholar
  69. 69.
    Patel S, Dhillon MS, Aggarwal S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013;41:356–64.PubMedCrossRefGoogle Scholar
  70. 70.
    Jang SJ, Kim JD, Cha SS. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol. 2013;23:573–80.PubMedCrossRefGoogle Scholar
  71. 71.
    Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011;27:1490–501.PubMedCrossRefGoogle Scholar
  72. 72.
    Borregaard N, Sorensen OE, Theilgaard-Monch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 2007;28:340–5.PubMedCrossRefGoogle Scholar
  73. 73.
    Yeaman MR, Tang YQ, Shen AJ, et al. Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun. 1997;65:1023–31.PubMedCentralPubMedGoogle Scholar
  74. 74.
    Krijgsveld J, Zaat SA, Meeldijk J, et al. Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem. 2000;275:20374–81.PubMedCrossRefGoogle Scholar
  75. 75.
    Yeaman MR. The role of platelets in antimicrobial host defense. Clin Infect Dis. 1997;25:951–68.PubMedCrossRefGoogle Scholar
  76. 76.
    Burnouf T, Chou M, Wu Y, et al. Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria. Transfusion. 2013;53:138–46.PubMedCrossRefGoogle Scholar
  77. 77.
    Englert SJ, Estep TH, Ellis-Stoll CC. Postoperative surgical chest and leg incision sites using platelet gel: a retrospective study. J Extra Corpor Technol. 2008;40:225–8.PubMedGoogle Scholar
  78. 78.
    Trowbridge CC, Stammers AH, Woods E, et al. Use of platelet gel and its effects on infection in cardiac surgery. J Extra Corpor Technol. 2005;37:381–6.PubMedGoogle Scholar
  79. 79.
    Cieslik-Bielecka A, Bielecki T, Gazdzik TS, et al. Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury. Transfus Apher Sci. 2009;41:9–12.PubMedCrossRefGoogle Scholar
  80. 80.
    Bielecki TM, Gazdzik TS, Arendt J, et al. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. J Bone Joint Surg Br. 2007;89:417–20.PubMedCrossRefGoogle Scholar
  81. 81.
    Li GY, Yin JM, Ding H, et al. Efficacy of leukocyte- and platelet-rich plasma gel (L-PRP gel) in treating osteomyelitis in a rabbit model. J Orthop Res. 2013;31:949–56.PubMedCrossRefGoogle Scholar
  82. 82.
    DiIorio TM, Burkholder JD, Good RP, et al. Platelet-rich plasma does not reduce blood loss or pain or improve range of motion after TKA. Clin Orthop Relat Res. 2012;470:138–43.PubMedCentralPubMedCrossRefGoogle Scholar
  83. 83.
    Gardner MJ, Demetrakopoulos D, Klepchick PR, et al. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop. 2007;31:309–13.PubMedCentralPubMedCrossRefGoogle Scholar
  84. 84.
    Horstmann WG, Slappendel R, van Hellemondt GG, et al. Autologous platelet gel in total knee arthroplasty: a prospective randomized study. Knee Surg Sports Traumatol Arthrosc. 2011;19:115–21.PubMedCrossRefGoogle Scholar
  85. 85.
    Bernasek TL, Burris RB, Fujii H, et al. Effect on blood loss and cost-effectiveness of pain cocktails, platelet-rich plasma, or fibrin sealant after total knee arthroplasty. J Arthroplasty. 2012;27:1448–51.PubMedCrossRefGoogle Scholar
  86. 86.
    Mei-Dan O, Carmont MR, Laver L, et al. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med. 2012;40:534–41.PubMedCrossRefGoogle Scholar
  87. 87.
    Sanchez M, Guadilla J, Fiz N, et al. Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology (Oxford). 2012;51:144–50.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Taralyn M. McCarrel
    • 1
  • Nathan A. Mall
    • 2
  • Andrew S. Lee
    • 2
  • Brian J. Cole
    • 2
  • Davietta C. Butty
    • 2
  • Lisa A. Fortier
    • 3
    Email author
  1. 1.Rood and Riddle Equine HospitalLexingtonUSA
  2. 2.Department of OrthopaedicsRush University Medical CenterChicagoUSA
  3. 3.College of Veterinary MedicineCornell UniversityIthacaUSA

Personalised recommendations